{
    "Trade/Device Name(s)": [
        "Elecsys HCG STAT",
        "Beta HCG STAT Test"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K203227",
    "Predicate Device Reference 510(k) Number(s)": [
        "K002148"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA"
    ],
    "Summary Letter Date": "October 31, 2020",
    "Summary Letter Received Date": "November 2, 2020",
    "Submission Date": "March 17, 2021",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum primary tube",
        "Li-Heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas e 601 immunoassay analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich principle"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Diagnostics Elecsys HCG STAT quantitative immunoassay for hCG detection on cobas e 601 analyzer",
    "Indications for Use Summary": "For in vitro quantitative determination of human chorionic gonadotropin (hCG) in human serum and plasma to aid in early detection of pregnancy",
    "fda_folder": "Clinical Chemistry"
}